Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4847-4858

  Taoka, Masato ^a   Morofuji, Noriaki ^b,g   Yamauchi, Yoshio ^a   Ojima, Hidenori ^c,h   Kubota, Daisuke ^b   Terukina, Goro ^a   Nobe, Yuko ^a   Nakayama, Hiroshi ^d   Takahashi, Nobuhiro ^e   Kosuge, Tomoo ^f   Isobe, Toshiaki ^a   Kondo, Tadashi ^b  

^a TOKYO METROPOLITAN UNIVERSITY   (Japan)

^b Division of Pharmacoproteomics   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d RIKEN   (Japan)

^e TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g Kumiai Kosei Hospital   (Japan)

^h KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

biomarker; hepatocellular carcinoma; mass spectrometry; proteomics; PROTOMAP

Indexed keywords

4 HYDROXYPHENYLPYRUVATE DIOXYGENASE; ALANINE TRANSFER RNA LIGASE; ALDEHYDE OXIDASE; APOLIPOPROTEIN B100; BETA TUBULIN; BIOLOGICAL MARKER; CARBAMOYL PHOSPHATE SYNTHASE; COENZYME A; COMPLEMENT COMPONENT C2; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYTOCHROME P450 3A4; DELTA CATENIN; FIBRONECTIN; GALACTOKINASE; GLUTAMINE TRANSFER RNA LIGASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; GUANINE DEAMINASE; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; LEUKOCYTE ELASTASE INHIBITOR; LIM PROTEIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN SH3; SARCOSINE DEHYDROGENASE; SERINE PROTEINASE INHIBITOR; STAT1 PROTEIN; TRYPTOPHAN TRANSFER RNA LIGASE; UNCLASSIFIED DRUG; UROCANATE HYDRATASE; VALINE TRANSFER RNA LIGASE; PROTEIN; TUMOR MARKER;

AMINOACYLATION; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CATALYSIS; CELL DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DETOXIFICATION; DOWN REGULATION; EARLY CANCER; GLOBAL CHANGE; HUMAN; HUMAN TISSUE; LIVER; LIVER CELL CARCINOMA; LIVER FUNCTION; NUCLEAR LOCALIZATION SIGNAL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEINASE INHIBITION; SIGNAL TRANSDUCTION; TUMOR RECURRENCE; UPREGULATION; UREA CYCLE; CARCINOMA, HEPATOCELLULAR; DENATURING GRADIENT GEL ELECTROPHORESIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LIVER NEOPLASMS; MASS SPECTROMETRY; METABOLISM; PROCEDURES; PROTEOMICS;

BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; DENATURING GRADIENT GEL ELECTROPHORESIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; PROTEINS; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84908884093     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500262p     Document Type: Article

References (62)

1. Bosch, F. X.; Ribes, J.; Borras, J. Epidemiology of primary liver cancer Semin. Liver Dis. 1999, 19 (3) 271-285
2. Bruix, J.; Llovet, J. M. Major achievements in hepatocellular carcinoma Lancet 2009, 373 (9664) 614-616
3. Dudek, K.; Kornasiewicz, O.; Remiszewski, P.; Kobryn, K.; Ziarkiewicz-Wroblewska, B.; Gornicka, B.; Zieniewicz, K.; Krawczyk, M. Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma Transplant. Proc. 2009, 41 (8) 3135-3137
4. Lim, K. C.; Chow, P. K.; Allen, J. C.; Chia, G. S.; Lim, M.; Cheow, P. C.; Chung, A. Y.; Ooi, L. L.; Tan, S. B. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria Ann. Surg. 2011, 254 (1) 108-113
5. Mazzaferro, V.; Llovet, J. M.; Miceli, R.; Bhoori, S.; Schiavo, M.; Mariani, L.; Camerini, T.; Roayaie, S.; Schwartz, M. E.; Grazi, G. L.; Adam, R.; Neuhaus, P.; Salizzoni, M.; Bruix, J.; Forner, A.; De Carlis, L.; Cillo, U.; Burroughs, A. K.; Troisi, R.; Rossi, M.; Gerunda, G. E.; Lerut, J.; Belghiti, J.; Boin, I.; Gugenheim, J.; Rochling, F.; Van Hoek, B.; Majno, P. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol. 2009, 10 (1) 35-43
6. Poon, R. T. Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies Ann. Surg. Oncol. 2009, 16 (4) 792-794
7. Roayaie, S.; Blume, I. N.; Thung, S. N.; Guido, M.; Fiel, M. I.; Hiotis, S.; Labow, D. M.; Llovet, J. M.; Schwartz, M. E. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma Gastroenterology 2009, 137 (3) 850-855
8. Llovet, J. M.; Bruix, J. Novel advancements in the management of hepatocellular carcinoma in 2008 J. Hepatol. 2008, 48 (Suppl 1) S20-S37
9. Iizuka, N.; Oka, M.; Yamada-Okabe, H.; Nishida, M.; Maeda, Y.; Mori, N.; Takao, T.; Tamesa, T.; Tangoku, A.; Tabuchi, H.; Hamada, K.; Nakayama, H.; Ishitsuka, H.; Miyamoto, T.; Hirabayashi, A.; Uchimura, S.; Hamamoto, Y. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection Lancet 2003, 361 (9361) 923-929
10. Ye, Q. H.; Qin, L. X.; Forgues, M.; He, P.; Kim, J. W.; Peng, A. C.; Simon, R.; Li, Y.; Robles, A. I.; Chen, Y.; Ma, Z. C.; Wu, Z. Q.; Ye, S. L.; Liu, Y. K.; Tang, Z. Y.; Wang, X. W. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat. Med. 2003, 9 (4) 416-423
11. Du, Y.; Cao, G. W. Challenges of incorporating gene expression data to predict HCC prognosis in the age of systems biology World J. Gastroenterol 2012, 18 (30) 3941-3944
12. Orimo, T.; Ojima, H.; Hiraoka, N.; Saito, S.; Kosuge, T.; Kakisaka, T.; Yokoo, H.; Nakanishi, K.; Kamiyama, T.; Todo, S.; Hirohashi, S.; Kondo, T. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma Hepatology 2008, 48 (6) 1851-1863
13. Bai, D. S.; Dai, Z.; Zhou, J.; Liu, Y. K.; Qiu, S. J.; Tan, C. J.; Shi, Y. H.; Huang, C.; Wang, Z.; He, Y. F.; Fan, J. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma Hepatology 2009, 49 (2) 460-470
14. Yi, X.; Luk, J. M.; Lee, N. P.; Peng, J.; Leng, X.; Guan, X. Y.; Lau, G. K.; Beretta, L.; Fan, S. T. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence Mol. Cell. Proteomics 2008, 7 (2) 315-325
15. Kanamori, H.; Kawakami, T.; Effendi, K.; Yamazaki, K.; Mori, T.; Ebinuma, H.; Masugi, Y.; Du, W.; Nagasaka, K.; Ogiwara, A.; Kyono, Y.; Tanabe, M.; Saito, H.; Hibi, T.; Sakamoto, M. Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma Oncology 2011, 80 (5-6) 406-415
16. Lee, S. H.; Shin, M. S.; Lee, H. S.; Bae, J. H.; Lee, H. K.; Kim, H. S.; Kim, S. Y.; Jang, J. J.; Joo, M.; Kang, Y. K.; Park, W. S.; Park, J. Y.; Oh, R. R.; Han, S. Y.; Lee, J. H.; Kim, S. H.; Lee, J. Y.; Yoo, N. J. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma Hum. Pathol. 2001, 32 (3) 250-256
17. Volkmann, M.; Schiff, J. H.; Hajjar, Y.; Otto, G.; Stilgenbauer, F.; Fiehn, W.; Galle, P. R.; Hofmann, W. J. Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma J. Mol. Med. (Heidelberg, Ger.) 2001, 79 (10) 594-600
18. Marquardt, J. U.; Galle, P. R.; Teufel, A. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies J. Hepatol. 2012, 56 (1) 267-275
19. Turgeon, V. L.; Houenou, L. J. The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system Brain Res. Rev. 1997, 25 (1) 85-95
20. Riewald, M.; Ruf, W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor Proc. Natl. Acad. Sci. U. S. A. 2001, 98 (14) 7742-7747
21. Alnemri, E. S. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases J. Cell Biochem. 1997, 64 (1) 33-42
22. Abdel-Rahman, H. M.; Kimura, T.; Hidaka, K.; Kiso, A.; Nezami, A.; Freire, E.; Hayashi, Y.; Kiso, Y. Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases Biol. Chem. 2004, 385 (11) 1035-1039
23. van Kempen, L. C.; de Visser, K. E.; Coussens, L. M. Inflammation, proteases and cancer Eur. J. Cancer 2006, 42 (6) 728-734
24. Quesada, V.; Ordonez, G. R.; Sanchez, L. M.; Puente, X. S.; Lopez-Otin, C. The Degradome database: mammalian proteases and diseases of proteolysis Nucleic Acids Res. 2009, 37 (Database issue) D239-D243
25. Nisman, B.; Biran, H.; Heching, N.; Barak, V.; Ramu, N.; Nemirovsky, I.; Peretz, T. Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival Br. J. Cancer 2008, 98 (1) 77-79
26. Streckfus, C.; Bigler, L.; Tucci, M.; Thigpen, J. T. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma Cancer Invest. 2000, 18 (2) 101-109
27. Dix, M. M.; Simon, G. M.; Cravatt, B. F. Global mapping of the topography and magnitude of proteolytic events in apoptosis Cell 2008, 134 (4) 679-691
28. Shen, C.; Yu, Y.; Li, H.; Yan, G.; Liu, M.; Shen, H.; Yang, P. Global profiling of proteolytically modified proteins in human metastatic hepatocellular carcinoma cell lines reveals CAPN2 centered network Proteomics 2012, 12 (12) 1917-1927
29. Ishihama, Y.; Oda, Y.; Tabata, T.; Sato, T.; Nagasu, T.; Rappsilber, J.; Mann, M. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein Mol. Cell. Proteomics 2005, 4 (9) 1265-1272
30. Taoka, M.; Wakamiya, A.; Nakayama, H.; Isobe, T. Protein profiling of rat cerebella during development Electrophoresis 2000, 21 (9) 1872-1879
31. Abiko, M.; Furuta, K.; Yamauchi, Y.; Fujita, C.; Taoka, M.; Isobe, T.; Okamoto, T. Identification of proteins enriched in rice egg or sperm cells by single-cell proteomics PLoS One 2013, 8 (7) e69578
32. Taoka, M.; Yamauchi, Y.; Nobe, Y.; Masaki, S.; Nakayama, H.; Ishikawa, H.; Takahashi, N.; Isobe, T. An analytical platform for mass spectrometry-based identification and chemical analysis of RNA in ribonucleoprotein complexes Nucleic Acids Res. 2009, 37 (21) e140
33. Shinkawa, T.; Taoka, M.; Yamauchi, Y.; Ichimura, T.; Kaji, H.; Takahashi, N.; Isobe, T. STEM: a software tool for large-scale proteomic data analyses J. Proteome Res. 2005, 4 (5) 1826-1831
34. Corrocher, R.; Casaril, M.; Bellisola, G.; Gabrielli, G. B.; Nicoli, N.; Guidi, G. C.; De Sandre, G. Severe impairment of antioxidant system in human hepatoma Cancer 1986, 58 (8) 1658-1662
35. Sato, K.; Ito, K.; Kohara, H.; Yamaguchi, Y.; Adachi, K.; Endo, H. Negative regulation of catalase gene expression in hepatoma cells Mol. Cell. Biol. 1992, 12 (6) 2525-2533
36. Sun, Y.; Oberley, L. W.; Oberley, T. D.; Elwell, J. H.; Sierra-Rivera, E. Lowered antioxidant enzymes in spontaneously transformed embryonic mouse liver cells in culture Carcinogenesis 1993, 14 (7) 1457-1463
37. Qiu, W.; David, D.; Zhou, B.; Chu, P. G.; Zhang, B.; Wu, M.; Xiao, J.; Han, T.; Zhu, Z.; Wang, T.; Liu, X.; Lopez, R.; Frankel, P.; Jong, A.; Yen, Y. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma Am. J. Pathol. 2003, 162 (6) 1961-1974
38. Ho, J. C.; Cheung, S. T.; Leung, K. L.; Ng, I. O.; Fan, S. T. Decreased expression of cytochrome P450 2E1 is associated with poor prognosis of hepatocellular carcinoma Int. J. Cancer 2004, 111 (4) 494-500
39. Ngoka, L. C. Dramatic down-regulation of oxidoreductases in human hepatocellular carcinoma hepG2 cells: proteomics and gene ontology unveiling new frontiers in cancer enzymology Proteome Sci. 2008, 6, 29
40. Wei, R. R.; Zhang, M. Y.; Rao, H. L.; Pu, H. Y.; Zhang, H. Z.; Wang, H. Y. Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma Med. Oncol 2012, 29 (4) 2737-2743
41. Jordan, C. T.; Guzman, M. L.; Noble, M. Cancer stem cells N. Engl J. Med. 2006, 355 (12) 1253-1261
42. Stark, G. R.; Darnell, J. E., Jr. The JAK-STAT pathway at twenty Immunity 2012, 36 (4) 503-514
43. Chen, X.; Vinkemeier, U.; Zhao, Y.; Jeruzalmi, D.; Darnell, J. E., Jr.; Kuriyan, J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA Cell 1998, 93 (5) 827-839
44. Menke, A.; Giehl, K. Regulation of adherens junctions by Rho GTPases and p120-catenin Arch. Biochem. Biophys. 2012, 524 (1) 48-55
45. McCrea, P. D.; Park, J. I. Developmental functions of the P120-catenin sub-family Biochim. Biophys. Acta 2007, 1773 (1) 17-33
46. Ishiyama, N.; Lee, S. H.; Liu, S.; Li, G. Y.; Smith, M. J.; Reichardt, L. F.; Ikura, M. Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion Cell 2010, 141 (1) 117-128
47. Torbenson, M.; Wang, J.; Choti, M.; Ashfaq, R.; Maitra, A.; Wilentz, R. E.; Boitnott, J. Hepatocellular carcinomas show abnormal expression of fibronectin protein Mod. Pathol. 2002, 15 (8) 826-830
48. Matsui, S.; Takahashi, T.; Oyanagi, Y.; Takahashi, S.; Boku, S.; Takahashi, K.; Furukawa, K.; Arai, F.; Asakura, H. Expression, localization and alternative splicing pattern of fibronectin messenger RNA in fibrotic human liver and hepatocellular carcinoma J. Hepatol. 1997, 27 (5) 843-853
49. Haglund, C.; Ylatupa, S.; Mertaniemi, P.; Partanen, P. Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA Br. J. Cancer 1997, 76 (6) 777-783
50. Chen, X. L.; Zhou, L.; Yang, J.; Shen, F. K.; Zhao, S. P.; Wang, Y. L. Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS Mol. Med. Rep. 2011, 3 (4) 589-596
51. Luk, J. M.; Lam, C. T.; Siu, A. F.; Lam, B. Y.; Ng, I. O.; Hu, M. Y.; Che, C. M.; Fan, S. T. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values Proteomics 2006, 6 (3) 1049-1057
52. Song, H. Y.; Liu, Y. K.; Feng, J. T.; Cui, J. F.; Dai, Z.; Zhang, L. J.; Feng, J. X.; Shen, H. L.; Tang, Z. Y. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues J. Cancer Res. Clin. Oncol. 2006, 132 (2) 92-98
53. Yokota, S.; Yamamoto, Y.; Shimizu, K.; Momoi, H.; Kamikawa, T.; Yamaoka, Y.; Yanagi, H.; Yura, T.; Kubota, H. Increased expression of cytosolic chaperonin CCT in human hepatocellular and colonic carcinoma Cell Stress Chaperones 2001, 6 (4) 345-350
54. Sung, Y. K.; Hwang, S. Y.; Park, M. K.; Bae, H. I.; Kim, W. H.; Kim, J. C.; Kim, M. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma Cancer Sci. 2003, 94 (5) 421-424
55. Liu, H.; Dong, H.; Robertson, K.; Liu, C. DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma Am. J. Pathol. 2011, 178 (2) 652-661
56. Cardona, D. M.; Zhang, X.; Liu, C. Loss of carbamoyl phosphate synthetase I in small-intestinal adenocarcinoma Am. J. Clin. Pathol. 2009, 132 (6) 877-882
57. Butler, S. L.; Dong, H.; Cardona, D.; Jia, M.; Zheng, R.; Zhu, H.; Crawford, J. M.; Liu, C. The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1 Lab. Invest. 2008, 88 (1) 78-88
58. Matos, J. M.; Witzmann, F. A.; Cummings, O. W.; Schmidt, C. M. A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States J. Surg. Res. 2009, 155 (2) 237-243
59. Sigruener, A.; Buechler, C.; Orso, E.; Hartmann, A.; Wild, P. J.; Terracciano, L.; Roncalli, M.; Bornstein, S. R.; Schmitz, G. Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes Horm. Metab. Res. 2007, 39 (11) 781-789
60. Chen, M.; Zhang, J.; Li, N.; Qian, Z.; Zhu, M.; Li, Q.; Zheng, J.; Wang, X.; Shi, G. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer PLoS One 2011, 6 (10) e25564
61. Liu, Z.; Ma, Y.; Yang, J.; Qin, H. Upregulated and downregulated proteins in hepatocellular carcinoma: a systematic review of proteomic profiling studies OMICS 2011, 15 (1-2) 61-71
62. Chen, X. Q.; He, J. R.; Wang, H. Y. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma Med. Oncol. 2012, 29 (3) 1843-1849